ReviewBritish journal of pharmacology2009

Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control?

David J Grieve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.